EG ELEMENT GENOMICS Trademark

Trademark Overview

On Friday, January 6, 2017, a trademark application was filed for EG ELEMENT GENOMICS with the United States Patent and Trademark Office. The USPTO has given the EG ELEMENT GENOMICS trademark a serial number of 87291550. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 27, 2025. This trademark is owned by Element Genomics, Inc.. The EG ELEMENT GENOMICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development relating to pharmaceutical preparations and formulations; Medical research; Scientific research and development relating to the discovery and validating of drug target genes; Drug discovery, design, and testing in the nature of conducting clinical trials, and formulation; Genetic testing services, namely, laboratory, technical research, consulting and analysis services in the field of genomics; Research and drug development services for the purposes of understanding gene regulatory elements in order to identify new drug targets for common diseases
eg element genomics

General Information

Serial Number87291550
Word MarkEG ELEMENT GENOMICS
Filing DateFriday, January 6, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 27, 2025
Registration Number5628467
Registration DateTuesday, December 11, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 13, 2018

Trademark Statements

Description of MarkThe mark consists of the letter "E" in upper case and the letter "G" in lower case and the words "ELEMENT GENOMICS" in title case below.
Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"GENOMICS"
Goods and ServicesResearch and development relating to pharmaceutical preparations and formulations; Medical research; Scientific research and development relating to the discovery and validating of drug target genes; Drug discovery, design, and testing in the nature of conducting clinical trials, and formulation; Genetic testing services, namely, laboratory, technical research, consulting and analysis services in the field of genomics; Research and drug development services for the purposes of understanding gene regulatory elements in order to identify new drug targets for common diseases

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 27, 2025
Primary Code042
First Use Anywhere DateTuesday, January 31, 2017
First Use In Commerce DateTuesday, January 31, 2017

Trademark Owner History

Party NameUCB BIOPHARMA SRL
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBRUSSELS B-1070
BE
Party NameElement Genomics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701
Party NameElement Genomics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDurham, NC 27701
Party NameElement Genomics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27701

Trademark Events

Event DateEvent Description
Friday, April 7, 2017NON-FINAL ACTION WRITTEN
Tuesday, January 10, 2017NEW APPLICATION ENTERED
Friday, January 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 30, 2017ASSIGNED TO EXAMINER
Friday, April 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 7, 2017NON-FINAL ACTION E-MAILED
Monday, October 9, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 9, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 10, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2017FINAL REFUSAL E-MAILED
Tuesday, October 31, 2017FINAL REFUSAL WRITTEN
Wednesday, December 13, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 31, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, December 12, 2017TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, December 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 3, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 24, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 13, 2018PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, October 10, 2018USE AMENDMENT FILED
Monday, November 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 6, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 7, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, December 11, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, August 24, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, February 13, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 10, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, November 5, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 27, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, December 27, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, December 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 27, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, December 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, December 27, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, December 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 27, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

genomics element research drug development services discovery testing relating purposes field